NCT05334680 is a clinical trial of ANNE Sensor in COVID-19, sponsored by Arun Jayaraman, PT, PhD.

Who is sponsoring NCT05334680?

NCT05334680 is sponsored by Arun Jayaraman, PT, PhD.

What drugs are being tested in NCT05334680?

Interventions in NCT05334680: ANNE Sensor.

Is NCT05334680 still recruiting?

NCT05334680 is currently status unknown. Last updated 19 January 2023.

Last reviewed 2023-01-19 · How we verify

NCT05334680

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms

Status unknown Last updated 19 January 2023

What this trial tests

trial testing ANNE Sensor in COVID-19 in 550 participants. Status unknown.

Timeline

24 June 2021

Primary endpoint
8 March 2023

31 December 2023

Quick facts

Lead sponsor	Arun Jayaraman, PT, PhD
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	550
Start date	24 June 2021
Primary completion	8 March 2023
Estimated completion	31 December 2023
Sites	3 locations across India

Drugs / interventions tested

ANNE Sensor

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Arun Jayaraman, PT, PhD

Who can join

Adults 18 to 95, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Deploy wearable COVID sensor to collect high resolution physiological data (temperature, cardiac, respiratory and physical activity) from COVID positive patients. 2. Use collected data to train algorithm for assessing the risk of individuals presenting with symptoms suggestive of COVID-19.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India).
Botonis OK, Mendley J, Aalla S, Veit NC, et al · · 2024 · PMID 39427067 · DOI 10.1038/s41746-024-01287-2

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Arun Jayaraman, PT, PhD trials

Trials by the same sponsor.

NCT04251091 — Ankle Exosuit Training in the Clinic to Community Community · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05334680 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arun Jayaraman, PT, PhD
Last refreshed: 19 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05334680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing